A 55 year-old man with unstable angina is treated with an intravenously administered glycoprotein IIb - IIIa inhibitor. The mechanism of action of this agent is the ability to.

Solution: Glycoprotein IIb - IIIa Prevent the action of the platelet surface receptor glycoprotein complex, which is mrequired for formation of fibrinogen bridges between adjacent platelets. Thus inhibiting platelet aggregation.